Search Results
Co-Manager on Dyne Therapeutics' Follow-On Offering
Oppenheimer & Co. Inc. acted as Co-Manager on Dyne Therapeutics’ $345MM Follow-On Offering
Capital Markets Advisor for Pinstripes, Inc.
Oppenheimer & Co. Inc. acted as Capital Markets Advisor for Pinstripes, Inc. on its $438,000,000 business combination with Banyan Acquisition Corp. (NYSE: BYN)
Active Joint Bookrunner for Evolent Health, Inc.
Oppenheimer & Co. Inc. acted as Active Joint Bookrunner for Evolent Health, Inc. on its $402.5 Million Convertible Senior Note Offering
A Tale of Two Markets: Why Do Things Look So Good But Feel So Bad?
A Tale of Two Markets: Why Do Things Look So Good But Feel So Bad?
Private Placement Activity and M&A and Strategic Collaborations
Oppenheimer's 2023 Year-in-Review and 2024 Outlook for Private Placement Activity and M&A and Strategic Collaborations are now available upon request.
Private Placement Activity and M&A and Strategic Collaborations
We are happy to share Oppenheimer's Quarterly Private Placement Insights as well as our M&A and Strategic Collaborations Insights. Spoiler Alert: The positive momentum from Q1 carried over into Q2 across the board.
The Art of Managing Monetary Policy Expectations
The Art of Managing Monetary Policy Expectations
Munis End February with Positive Performance Thanks to Technicals
Munis End February with Positive Performance Thanks to Technicals
Muni Performance Leading Into The Ides Of March
Muni Performance Leading Into The Ides Of March